ACE I/D genetic polymorphism as a risk factor of essential hypertension

View or download the full article: 
PDF icon health-risk-analysis-2022-3-16.pdf
UDC: 
577: 575: 614.8.086 (470.54)
DOI: 
10.21668/health.risk/2022.3.16.eng
Authors: 

K.G. Starkova, О.V. Dolgikh, О.А. Kazakova, Т.А. Legostaeva

Organization: 

Federal Scientific Center for Medical and Preventive Health Risk Management Technologies, 82 Monastyrskaya Str., Perm, 614045, Russian Federation

Abstract: 

Examining genetic mechanisms of essential hypertension as a cardiovascular risk factor will make it possible to provide monitoring of public health using a personified approach to early diagnostics of cardiovascular pathologies. This will raise effectiveness of preventive activities aimed at reducing population mortality.

Our research goal was to examine features of ACE (the angiotensin-converting enzyme) I/D gene polymorphism (rs4646994) as a risk factor of essential hypertension.

Our test group included 35 people with diagnosed essential hypertension; the reference group was made of 34 relatively healthy people. Lipid spectrum indicators were estimated with an automated or semi-automated analyzer or by calculation. Insulin and cytokines were determined by using the enzyme immunoassay. Genotyping was performed by using the polymerase chain reaction in real time mode.

The research results revealed that the examined patients with essential hypertension had authentic differences from the reference group regarding BMI, lipid spectrum indicators with very low density lipoproteins and triglycerides contents being by 1.3 times higher; insulin contents, by 1.9 times higher; IL-6 contents, by 2.2 times higher; and VEGF, by 1.4 times higher. Genetic analysis revealed 1.3-time higher prevalence of the D-allele of the ACE I/D gene in the patients with essential hypertension (we showed that the dominant inheritance was adequate, P = 0.041). The carriage of this allele was associated with the analyzed disease (OR = 3.16; 95 % CI = 1.08–9.20).

We showed an association between insertion-deletion polymorphisms of the ACE (the angiotensin-converting enzyme) I/D gene and developing essential hypertension in the examined test group (the relative risk was RR = 1.87; 95 % CI =1.07–3.61). This polymorphism can be considered a potential marker of sensitivity to developing essential hypertension.

Keywords: 
essential hypertension, angiotensin converting enzyme, ACE I/D polymorphism, dyslipidemia, pro-inflammatory cytokines
Starkova K.G., Dolgikh О.V., Kazakova О.А., Legostaeva Т.А. Ace I/D genetic polymorphism as a risk factor of essential hypertension. Health Risk Analysis, 2022, no. 3, pp. 169–175. DOI: 10.21668/health.risk/2022.3.16.eng
References: 
  1. Elkina A.Yu., Akimova N.S., Shvartz Yu.G. Polymorphic variants of the renin-angiotensin-aldosterone system genes associated with the risk of hypertension development (review). Saratovskii nauchno-meditsinskii zhurnal, 2020, vol. 16, no. 3, pp. 724–728 (in Russian).
  2. Bhatti G.K., Bhatti J.S., Vijayvergiya R., Singh B. Implications of ACE (I/D) gene variants to the genetic susceptibility of coronary artery disease in Asian Indians. Indian J. Clin. Biochem., 2017, vol. 32, no. 2, pp. 163–170. DOI: 10.1007/s12291-016-0588-3
  3. Krishnan R., Sekar D., Karunanithy S., Subramanium S. Association of angiotensin converting enzyme gene inser-tion/deletion polymorphism with essential hypertension in south Indian population. Genes Dis., 2016, vol. 3, no. 2, pp. 159–163. DOI: 10.1016/j.gendis.2016.03.001
  4. Mani D., Chinniah R., Ravi P., Swaminathan K., Janarthanan R. A., Vijayan M., Raju K., Karuppiah B. Predisposition of angiotensin-converting enzyme deletion/deletion genotype to coronary artery disease with type 2 diabetes mellitus in South India. Indian J. Endocrinol. Metab., 2017, vol. 21, no. 6, pp. 882–885. DOI: 10.4103/ijem.IJEM_215_17
  5. Pachocka L., Włodarczyk M., Kłosiewicz-Latoszek L., Stolarska I. The association between the insertion/deletion polymorphism of the angiotensin converting enzyme gene and hypertension, as well as environmental, biochemical and anthro-pometric factors. Rocz. Panstw. Zakl. Hig., 2020, vol. 71, no. 2, pp. 207–214. DOI: 10.32394/rpzh.2020.0119
  6. Akopyan A.A., Strazhesko I.D., Tkacheva O.N., Yesakova A.P., Orlova I.A. Review of polymorphisms, associated with cardiovascular diseases. Rossiyskii zhurnal geriatricheskoi meditsiny, 2020, no. 4, pp. 333–338. DOI: 10.37586/2686-8636-4-2020-333-338 (in Russian).
  7. Liu M., Yi J., Tang W. Association between angiotensin converting enzyme gene polymorphism and essential hyperten-sion: A systematic review and meta-analysis. J. Renin Angiotensin Aldosterone Syst., 2021, vol. 22, no. 1, pp. 1470320321995074. DOI: 10.1177/1470320321995074
  8. Lv Y., Zhao W., Yu L., Yu J.-G., Zhao L. Angiotensin-converting enzyme gene D/I polymorphism in relation to endothelial function and endothelial-released factors in Chinese women. Front. Physiol., 2020, vol. 11, pp. 951. DOI: 10.3389/fphys.2020.00951
  9. Simonyte S., Kuciene R., Medzioniene J., Dulskiene V., Lesauskaite V. Renin-angiotensin system gene polymorphisms and high blood pressure in Lithuanian children and adolescents. BMC Med. Genet., 2017, vol. 18, no. 1, pp. 100. DOI: 10.1186/s12881-017-0462-z
  10. Martynovich T.V., Akimova N.S., Fedotov E.A., Korsunova E.N., Sokolov I.M. Analysis of polymorphism of genes of the renin-angiotensin-aldosterone system in patients with cardiovascular diseases. Sovremennyye problemy nauki i obra-zovaniya, 2015, no. 3. Available at: https://science-education.ru/en/article/view?id=17392 (02.08.2022) (in Russian).
  11. Amara A., Mrad M., Sayeh A., Lahideb D., Layouni S., Haggui A., Fekih-Mrissa N., Haouala H., Nsiri B. The Effect of ACE I/D polymorphisms alone and with concomitant risk factors on coronary artery disease. Clin. Appl. Thromb. Hemost., 2018, vol. 24, no. 1, pp. 157–163. DOI: 10.1177/1076029616679505
  12. Shakhanova A.Т., Aukenov N.E., Nurtazina A.U., Shakhanov T.E., Kozhakhmetova D.K. Interrelation of insulin re-sistance and polymorphisms of genes in lipid metabolism genes and renin-angiotensin-aldosterone system. Literature review. Nauka i zdravookhranenie, 2019, vol. 21, no. 4, pp. 50–59 (in Russian).
  13. Nouryazdan N., Adibhesami G., Birjandi M., Heydari R., Yalameha B., Shahsavari G. Study of angiotensin-converting enzyme insertion/deletion polymorphism, enzyme activity and oxidized low density lipoprotein in Western Iranians with atheroscle-rosis: a case-control study. BMC Cardiovasc. Disord., 2019, vol. 19, no. 1, pp. 184. DOI: 10.1186/s12872-019-1158-4
  14. Motawi T.K., Shaker O.G., Shahin N.N., Ahmed N.M. Angiotensin-converting enzyme insertion/deletion polymor-phism association with obesity and some related disorders in Egyptian females: a case-control observational study. Nutr. Metab. (Lond)., 2016, vol. 13, pp. 68. DOI: 10.1186/s12986-016-0127-5
  15. Kubatova A.P., Zotova T.Yu., Azova M.M., Aissa A. Ait. The ACE gene polymorism influence on the course of hy-pertension in the Caucasians as part of the metabolic syndrome. Vestnik novykh meditsinskikh tekhnologii, 2016, vol. 23, no. 4, pp. 66–70. DOI: 10.12737/23852 (in Russian).
  16. Carnagarin R., Matthews V., Zaldivia M.T.K., Peter K., Schlaich M.P. The bidirectional interaction between the sym-pathetic nervous system and immune mechanisms in the pathogenesis of hypertension. British Journal of Pharmacology, 2019, vol. 176, no. 12, pp. 1839–1852. DOI: 10.1111/bph.14481
  17. Shinetova L.E., Omar A., Elubaeva L., Akparova A.Y., Bersimbay R.I. Cytokines and hypertension. Vestnik KazNMU, 2017, no. 1, pp. 264–268 (in Russian).
  18. Didion S.P. Cellular and oxidative mechanisms associated with interleukin-6 signaling in the vasculature. Int. J. Mol. Sci., 2017, vol. 18, no. 12, pp. 2563. DOI: 10.3390/ijms18122563
  19. Polozova E.I., Puzanova E.V., Seskina A.A. Role of immunological disorders, endothelial dysfunction and hemostatic disorders in the genesis of arterial hypertension in the metabolic syndrome. Meditsinskaya immunologiya, 2020, vol. 22, no. 2, pp. 221–230. DOI: 10.15789/1563-0625-ROI-1926 (in Russian).
  20. Gubareva E.Yu., Gubareva I.V. Vascular endothelial growth factor as a potential marker of subclinical organ damage mediated by arterial hypertension. Sibirskii meditsinskii zhurnal, 2019, vol. 34, no. 3, pp. 40–44. DOI: 10.29001/2073-8552-2019-34-3-40-44 (in Russian).
  21. Hadian B., Zafarmohtashami A., Chaghervand Z., Nouryazdan N. Angiotensin-converting enzyme gene inser-tion/deletion polymorphism and hypertension disease. Arch. Physiol. Biochem., 2020, vol. 128, no. 5, pp. 1165–1169. DOI: 10.1080/13813455.2020.176222522
  22. Muzhenya D.V., Tuguz A.R., Lysenkov S.P., Thakushinov R.A., Ozheva R.S. Role of gene polymorphism of the ren-in-angiotensin system components in development of cardiovascular diseases, excess body weight and obesity in inhabitants of the Adygea Republic. Vestnik Sankt-Peterburgskogo universiteta. Meditsina, 2018, vol. 13, no. 4, pp. 344–354. DOI: 10.21638/11701/spbu11.2018.402 (in Russian).
  23. Zaitseva N.V., Zemlianova M.A., Dolgikh О.V. Genomic, transcriptomic and proteomic technologies as a modern tool for health disorders diagnostics, associated with the impact of environmental factors. Gigiena i sanitariya, 2020, vol. 99, no. 1, pp. 6–12. DOI: 10.33029/0016-9900-2020-99-1-6-12 (in Russian).
  24. Nikonoshina N.A., Zaitseva N.V., Dolgikh O.V. Analysis of the features of immune regulation in men with a diagnosis of atherosclerosis associated with candidate gene polymorphism (by the example of Perm region). Byulleten' eksperimental'noi biologii i meditsiny, 2020, vol. 170, no. 11, pp. 608–612. DOI: 10.47056/0365-9615-2020-170-11-608-612 (in Russian).
  25. Zaitseva N.V., Zemlyanova M.A., Chashchin V.P., Gudkov A.B. Scientifiic principles of use of biomarkers in medico-ecological studies (review). Ekologiya cheloveka, 2019, vol. 26, no. 9, pp. 4–14. DOI: 10.33396/1728-0869-2019-9-4-14 (in Russian).
Received: 
19.06.2022
Approved: 
23.09.2022
Accepted for publication: 
26.09.2022

You are here

Home